Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
North America Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet’s Disease, Obesity, and Others), Test Type [Invasive Tests and Non-Invasive Tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)
... (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others) The North America endothelial dysfunction market is expected to grow from US$ 951.83 million in 2022 ... Read More
-
Continuous Glucose Monitors Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
... Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Continuous Glucose Monitors pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Diabetic Footwear Global Market Report 2024
... Inc.; Dr. Zen Products Inc.; Orthofeet Inc. Diabetic Footwear Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This ... Read More
-
Insulin Patch Pumps Global Market Report 2024
... Diabetes; Type 2 Diabetes5) By End-User: Hospital; Clinics; LaboratoriesCovering: Cellnovo Group SA; Insulet Corporation; Medtronic PLC; Tandem Diabetes Care Inc.; Hoffmann-La-Roche AG Insulin Patch Pumps Global Market Report 2024 from The Business Research Company provides ... Read More
-
Asia Pacific Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare)
... and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare) The Asia Pacific glucose monitoring devices market is expected to grow from US$ 3,386.90 million in 2022 to US$ 8,471.46 million by 2030. It ... Read More
-
United States In Vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents & Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Haemostasias, Urinalysis, Others] By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F
... By Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F United States in vitro ... Read More
-
Australia In Vitro Diagnostics Market Assessment By Product Type [Instruments, Reagents & Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Haemostasias, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Ophthalmology, Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F
... Application [Ophthalmology, Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F Australia in vitro diagnostics ... Read More
-
India In Vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents & Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Haemostasis, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F India in vitro diagnostics market ... Read More
-
South & Central America Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare)
... (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare) The South & Central America glucose monitoring devices market is expected to grow from US$ 1,245.06 million in 2022 to US$ 2,795.05 ... Read More
-
Europe Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare)
... Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare) The Europe glucose monitoring devices market is expected to grow from US$ 5,248.87 million in 2022 to US$ 12,118.27 million by 2030. It is estimated ... Read More
-
Europe Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet’s Disease, Obesity, and Others), Test Type [Invasive Tests and Non-Invasive Tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)
... Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others) The Europe endothelial dysfunction market is expected to grow from US$ 611.28 million in 2022 to US$ ... Read More
-
North America Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare)
... and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare) The North America glucose monitoring devices market is expected to grow from US$ 5,987.78 million in 2022 to US$ 14,409.58 million by 2030. It ... Read More
-
Japan In Vitro Diagnostics Market Assessment By Product Type [Instruments, Reagents and Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Haemostasias, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... Application [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F Japan In Vitro Diagnostics Market size ... Read More
-
Middle East & Africa Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare)
... (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare) The Middle East & Africa glucose monitoring devices market is expected to grow from US$ 935.02 million in 2022 to US$ 1,736.39 ... Read More
-
Insulin Pump Market Size, Share & Trends Analysis Report, By Type (Patch, Tethered), By Accessories (Insulin Reservoir Or Cartridges, Insulin Set Insertion Devices, Battery), By End-use, By Region, And Segment Forecasts, 2023 - 2030
... Pump Market Growth & Trends The global insulin pump market size is expected to reach USD 8.6 billion, according to a new report by Grand View Research, Inc. The market is expected to expand at ... Read More
-
Global Incretin Based Drugs Market (2023 Edition)
... Analytics has released a research report titled “Incretin Based Drugs Market (2023 Edition)” which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 ... Read More
-
Patient-controlled Analgesic Pumps Market Size, Share & Trends Analysis Report By Type (Electronic, Mechanical), By Application (Diabetes, Oncology, Gastroenterology, Hematology), By End Use, By Region, And Segment Forecasts, 2023 - 2030
... Growth & Trends The global patient-controlled analgesic pumps market size is expected to reach USD 656.5 million by 2030, registering a CAGR of 5.9% from 2023 to 2030, according to a new report by Grand ... Read More
-
Global Home Infusion Therapy Market: Analysis By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, and Needleless Connectors), By Application (Anti-infective, Endocrinology, Enteral Nutrition, Specialty Pharmaceuticals, Hydration Therapy, Chemotherapy, and Others), By Route of Administration (Intramuscular, Subcutaneously, and Epidural), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
... Subcutaneously, and Epidural), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028 The global home infusion therapy market in 2022 was valued at US$23.55 billion. The market is expected to ... Read More
-
Spain Insulin Delivery Devices Market Overview, 2028
... Diabetes's impact on public health and the healthcare system emphasises the significance of finding novel ways to manage this chronic condition. The insulin delivery device industry in Spain is experiencing a spike in technological improvements. ... Read More
-
Spain Blood Glucose Monitor Market Overview, 2028
... diabetic monitoring devices has increased dramatically in recent years as a result of many major variables peculiar to the Spanish healthcare scene. Diabetes, a chronic health problem that affects a considerable section of the Spanish ... Read More
-
Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024
... Novo Nordisk A/S; Eli Lilly and Company; Medtronic plc; Abbott Laboratories; Insulet Corporation Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with ... Read More
-
Global Non-invasive Glucose Monitoring Devices Market 2024-2028
... on the non-invasive glucose monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Biologics, Therapy Devices), By Ulcer Type (Ischemic, Neuropathic), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2024 - 2030
... Ulcer Treatment Market Growth & Trends The global diabetic foot ulcer treatment market size is expected to reach USD 7.76 billion by 2030, registering a CAGR of 6.0% from 2024 to 2030, according to a ... Read More
-
Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
... Key Companies, 2023 Update provides comprehensive information about the Artificial Pancreas pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Artificial ... Read More
-
Rapid Acting Insulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 9.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4.61% during 2022-2028. The increasing risks of severity and mortality among patients, the growing focus on personalized medicine among the masses, and the ... Read More
Research Assistance
